1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. EXELIXIS INC
Exelixis Inc XNAS: EXEL
Mid-range Performer
Download real time
44.04 -0.11 (-0.25%)
38.06% Gain from 52W Low
2.8M
XNAS Volume

XNAS 09 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Exelixis Inc is on 12 Jan 2026 for the purpose of J.P. Morgan 2026 Healthcare Conference See details

Exelixis Inc - EXEL - stock price prediction, stock price target, analyst ratings from 20 analysts

Exelixis Inc has a share price target of US$ 46, revenue growth forecast of 7.6%, and profit growth estimate of 37.8% for FY25, based on top 20 analyst calls.

Forecaster Screeners